
In this episode of the podcast, Shawn and Jesse discuss how every situation has a solution and the best way to find it.

In this episode of the podcast, Shawn and Jesse discuss how every situation has a solution and the best way to find it.

Amid record levels of advertisements for lifestyle medications on social media, Luke Turnock, PhD, discusses the global impact these trends may have on patients.

In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.

Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.

LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.

Throughout her research, Jenny Markell, BA, has uncovered some alarming trends within prescription drug advertising in the US.

With expertise in the management and treatment of diabetes, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, shared her insights on counseling patients using GLP-1 medications.

In this episode of the podcast, Shawn and Jesse outline 3 key principles about teamwork that can drive success in the pharmacy.

Jeffrey Bratberg, PharmD and Madi Hartling, a 2025 PharmD candidate, discuss the lack of pharmacists in medical shows and how pharmacists are typically portrayed negatively in media.

According to data science expert Don Roosan, PharmD, PhD, the capabilities of ChatGPT are just the beginning of what the future of artificial intelligence may look like in pharmacy practice.

Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.

With minimal pharmacological treatments coming to market for chronic pain, researchers have explored new technologies for advancing pain treatment across the globe.

Join Shawn Bjorndal, PharmD, RPh, and Jesse McCullough, PharmD, for the first episode of Dispensing Leadership, a new podcast from Drug Topics® and RPhAlly.

The Cut Hypertension Program operates in barbershops across the Bay Area in California. The program’s lead pharmacist joined us to discuss main themes and goals of the new initiative.

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.

Erin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.

Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed gaps within primary care in the context of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.

Joseph DiPiro, PharmD, FCCP, FAAAS, broke down the importance of the ASHP Pharmacy Forecast and the process in which its content is curated.

The new initiative is a way for NCPA to proactively engage its network of community pharmacies during a potential public health crisis.

Known as “The Nutrition Pharmacist,” Sarah Gray, PharmD, GAICD, recently joined Drug Topics to discuss her dual profession within health care.

Jeremy Cundiff, PharmD, co-owner of Professional Pharmacy Group, joined Drug Topics to discuss Return Solutions and the company’s Rx Returns process.

Drug Topics sat down with Sandra Canally, RN, founder and CEO of The Compliance Team, and Kara Benson, PharmD, long-term care director of Lewis Drug Inc, to discuss the future of LTC pharmacy.

Listen to the first episode of RPHCast, where Kevin and Donna educate you on all things statins, blood pressure, cholesterol, and as many curves as you can imagine.

Eric Levin, CEO of Scripta Insights, discusses how "positive disruption" from private companies are positioned to confront challenges within the pharmaceutical industry.